Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsu.edu.ru/handle/123456789/36879
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLynchak, O. V.-
dc.contributor.authorPrylutskyy, Y. I.-
dc.contributor.authorRybalchenko, V. K.-
dc.contributor.authorKyzyma, O. A.-
dc.contributor.authorEvstigneev, M. P.-
dc.date.accessioned2021-01-15T12:25:48Z-
dc.date.available2021-01-15T12:25:48Z-
dc.date.issued2017-
dc.identifier.citationComparative analysis of the antineoplastic activity of C60 fullerene with 5-fluorouracil and pyrrole derivative in vivo / O.V. Lynchak [et al.] // Nanoscale Research Letters. - 2017. - Vol.12, №1. - Art.8. - URL: https://nanoscalereslett.springeropen.com/articles/10.1186/s11671-016-1775-0.-
dc.identifier.urihttp://dspace.bsu.edu.ru/handle/123456789/36879-
dc.description.abstractThe antitumor activity of pristine C60 fullerene aqueous solution (C60FAS) compared to 5-fluorouracil (5-FU) and pyrrole derivative 1-(4-Cl-benzyl)-3-Cl-4-(CF3-fenylamino)-1H-pyrrol-2.5-dione (MI-1) cytostatic drugs was investigated and analyzed in detail using the model of colorectal cancer induced by 1.2-dimethylhydrazine (DMH) in rats-
dc.language.isoen-
dc.rights2-s2.0-85008517744-
dc.subjectfullerene-
dc.subjectfluorouracil-
dc.subjectpyrrole derivative-
dc.subjectcolorectal cancer-
dc.subjectX-ray scattering-
dc.subjectmolecular modeling-
dc.titleComparative analysis of the antineoplastic activity of C60 fullerene with 5-fluorouracil and pyrrole derivative in vivo-
dc.typeArticle-
dc.identifier.citationpublicationNanoscale Research Letters-
dc.identifier.citationnumber1-
dc.identifier.citationvolume12-
Appears in Collections:Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)

Files in This Item:
File Description SizeFormat 
Comparative_Analysis_of_the_Antineoplast.pdf582.84 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.